Performance, Feasibility, and Safety Study for a Novel Endoluminal Robotic System for En-Bloc Resection of Bladder Tumours: First-In-Human Trial

This is a prospective, single-arm study to evaluate the feasibility and safety of performing transurethral en-bloc resection of bladder tumours using the Zenith robotic system.

Trial Details

NCT ID
NCT06281080
Phase
NA
Sponsor
Chinese University of Hong Kong
Status
RECRUITING
Cancer Type
Bladder Cancer
Interventions
  • En-Bloc Resection of Bladder Tumours
Locations (sample)
  • Shatin, Hong Kong|22.38333,114.18333

Key Eligibility Criteria

  • Age between 18 and 75 years
  • Body mass index \<35 kg/m2
  • Bladder tumour located \<3 cm in size; clinically non-muscle invasive bladder tumour
  • Clinically indicated for en-bloc resection.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Bladder Cancer Trials on Trialify →